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Summary
Postsynaptic AMPA receptor (AMPAR) trafficking me-
diates some forms of synaptic plasticity that are mod-
ulated by NMDA receptor (NMDAR) activation and
N-ethylmaleimide sensitive factor (NSF). We report
that NSF is physiologically S-nitrosylated by endoge-
nous, neuronally derived nitric oxide (NO). S-nitrosy-
lation of NSF augments its binding to the AMPAR
GluR2 subunit. Surface insertion of GluR2 in re-
sponse to activation of synaptic NMDARs requires
endogenous NO, acting selectively upon the binding
of NSF to GluR2. Thus, AMPAR recycling elicited by
NMDA neurotransmission is mediated by a cascade
involving NMDA activation of neuronal NO synthase
to form NO, leading to S-nitrosylation of NSF which
is thereby activated, enabling it to bind to GluR2 and
promote the receptor’s surface expression.
Introduction
AMPA receptors (AMPARs) mediate various forms of
synaptic plasticity by cycling into and out of postsyn-
aptic sites (Song and Huganir, 2002; Barry and Ziff,
2002; Sheng and Hyoung Lee, 2003; Collingridge and
Isaac, 2003). N-ethylmaleimide sensitive factor (NSF),
first identified as an ATPase that modulates vesicular
transport (Block et al., 1988; Sollner et al., 1993b), influ-
ences excitatory synaptic transmission by stabilizing or
recycling AMPARs into postsynaptic membranes (Lee
et al., 2002; Braithwaite et al., 2002). In this process,
NSF binds to the AMPAR subunit GluR2 (Song et al.,
1998; Osten et al., 1998; Nishimune et al., 1998) and
dissembles the GluR2/PICK1 protein complex (Hanley
et al., 2002) that regulates cerebellar long-term depres-
sion (LTD) (Xia et al., 2000; Steinberg et al., 2004).
NMDA receptor (NMDAR) activation regulates AMPAR
disposition (Shi et al., 1999). NMDARs are coupled to
neuronal nitric oxide synthase (nNOS) via PSD95 (Bren-
man et al., 1996) with NMDAR transmission activating
nNOS (Bredt and Snyder, 1989; Garthwaite et al., 1989).*Correspondence: ssnyder@bs.jhmi.eduSynaptic actions of NO involve stimulation of soluble
guanylyl cyclase to form cGMP (Bredt and Snyder,
1989) as well as S-nitrosylation of cysteines in multiple
target proteins (Jaffrey et al., 2001; Stamler et al., 2001;
Choi et al., 2000) which may explain cGMP-independent
mechanisms in long-term potentiation (LTP) (Lev-Ram
et al., 2002). NSF might be a target for NO-mediated
S-nitrosylation, as its name derives from its sensitivity
to N-ethylmaleimide, which alkylates sulfhydroyl groups
of cysteines in proteins (Block et al., 1988). Recently,
Lowenstein and associates (Matsushita et al., 2003)
identified NO-mediated S-nitrosylation of NSF as a reg-
ulator of exocytosis of endothelial granules.
We now report that S-nitrosylation of NSF enhances
its binding to GluR2 and that such binding is reduced
in nNOS-deficient mice. Moreover, surface expression
of GluR2 is regulated by NO and NSF-GluR2 interac-
tions. Thus, S-nitrosylation of NSF is a physiologic me-
diator of the receptor’s surface expression during the
induction of synaptic plasticity.
Results and Discussion
To ascertain whether NSF is physiologically nitrosy-
lated in the brain, we employed the biotin-switch tech-
nique (Jaffrey et al., 2001; Jaffrey et al., 2002). We de-
tect S-nitrosylated NSF in mouse brain under basal
conditions with loss of S-nitrosylation in nNOS-deleted
mice (Figure 1A). ATPase α1, previously shown to be
physiologically S-nitrosylated (Jaffrey et al., 2001), is
also S-nitrosylated under our experimental conditions
with nitrosylation absent in nNOS knockout mice. By
contrast, synaptophysin is not S-nitrosylated.
NSF is an ATPase, and its binding to GluR2 is dis-
rupted by ATP degradation (Hanley et al., 2002). Thus,
we fail to observe NSF binding to GluR2 in the presence
of ATP but detect modest levels of such binding with
the nonmetabolized ATPγS or AMP-PNP (Figure 1B).
Binding is markedly augmented by treatment with the
NO donors S-nitrosoglutathione (GSNO), S-nitroso-
N-penicillamine (SNAP), and 3-morpholinosydnonimine
(SIN1) in the presence of ATPγS or AMP-PNP (Figure
1B), but not ATP (Figure 1C). Stimulation by NO of NSF-
GluR2 binding in rat brain lysate might be secondary to
actions of NO on other proteins. To evaluate a direct
influence of NO upon NSF-GluR2 binding, we utilized a
C-terminal domain of GluR2 tagged with GST and His-
tagged NSF (Figure 1D). We observe substantial aug-
mentation of the binding of the two proteins in the
presence of the NO donors GSNO, SNAP, and SIN1,
indicating that NO acts directly upon these proteins.
We wondered whether endogenous neuronally derived
NO regulates the binding of NSF to GluR2. Accordingly,
we examined the binding of NSF to GluR2 in mice with
targeted deletion of nNOS (Figures 1E and 1F). NSF
does not efficiently coimmunoprecipitate with GluR2 in
hippocampal lysate (Figure 1B), so it is difficult to com-
pare NSF-GluR2 binding of wild-type and nNOS knock-
out mice under basal conditions. Electroconvulsive
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Figure 1. S-Nitrosylation of NSF Enhances the Association of NSF i
iand GluR2
t(A) In vivo S-nitrosylation of NSF in mouse brain. Cerebellar lysates
were prepared from nNOS+/+ and nNOS−/− mice. S-nitrosylated pro- t
teins were labeled with biotin, isolated with streptavidin-agarose t
beads, and visualized by Western blot. (B) Coimmunoprecipitation S
of NSF and GluR2. Rat hippocampal lysates were treated with NO o
donors in the presence of 0.5 mM AMP-PNP for 4 hr at 4°C. NSF
(and GluR2 were coimmunoprecipitated by an antibody against the
aGluR2 N terminus. The precipitated proteins were detected by im-
munoblot using anti-NSF and GluR2 antibodies. (C) Coimmuno- n
precipitation as described in (A) was also performed in the pres- t
ence of 0.5 mM ATP. (D) NO enhances in vitro binding of His-NSF t
to GST-GluR2 C terminus. Recombinant His-NSF (2 g) was pre-
treated with NO donors and then incubated with 2 g of GST-GluR2
fC-tail fusion protein in the presence of 0.5 mM AMP-PNP. Protein
bcomplexes were captured by GST beads and visualized by immu-
noblot using anti-His or anti-GST antibodies. (E) Reduced binding c
of NSF to GluR2 in nNOS−/− mice. Hippocampal lysates were pre- F
pared from nNOS+/+ and nNOS−/− mice which had received a single i
electroconvulsive shock. NSF and GluR2 were coimmunoprecipi- t
tated without NO donors and detected by immunoblot. (F) Quantifi-
vcation of coimmunoprecipitated NSF. Levels of bound NSF from
ccoimmunoprecipitation were normalized to those of coprecipitated
GluR2. Data are presented as mean ± SEM from four paired mice a
(0.18 ± 0.01 for nNOS+/+ mice; 0.12 ± 0.02 for nNOS−/− mice; *p < t
0.05). (G) MALDI-TOF identifies cysteine 91 as a target of S-nitrosy- T
lation in NSF. Recombinant NSF was in vitro S-nitrosylated with t
100 M GSNO and then digested with trypsin. MALDI-TOF mass
sspectrometry reveals a mass peak at 2511.58 m/z close to the bio-
ftinylated fragment with a cysteine at position 91 (AKQCIGTMTI
EIDFLQK) (expected mass of 2511.71 m/z). (H) Nitrosylated cys- t
teine 91 at the N terminus of NSF mediates the association of NSF
and GluR2. Cysteine mutants of NSF were pretreated with 0.2 mM
SNAP and then incubated with GST-GluR2 C-tail. The bound pro-
0teins were captured by GST beads and detected by immunoblot.
(I) Quantification of NSF-GluR2 binding. The bound recombinant C
MNSF and its mutants were normalized to GST-R2 (2.26 ± 0.6, 2.38 ±rafficking in HEK293 cells expressing functional AMPA
.46, 3.13 ± 1.04, and 1.10 ± 0.09 for wild-type, C11A, C21A, and
91A, respectively). Data are presented as mean ± SEM (n = 4).
utant C91A differs from wild-type and other mutants (*p < 0.05).hock (ECS) enhances neurotransmitter release and ac-
ivates NOS (Newman et al., 1998; Ishizuka et al., 2000).
ccordingly, we employed coimmunoprecipitation ex-
eriments in hippocampal tissue from mice subjected
o ECS. NSF-GluR2 binding is diminished by about
0% in the nNOS knockout mice. ECS involves multiple
rocesses in the brain, many of which are presumably
nrelated to NO (Kim et al., 2002; Matveeva et al., 2001;
hung et al., 2003). These may account for the rela-
ively modest decline in binding associated with nNOS
eletion in mice subjected to ECS. To examine the role
f NO in a less complex system, we employed cortical
ultures and activated NMDARs with glycine which
timulates NSF-GluR2 binding (see Figure S3 in the
upplemental Data available with this article online).
he augmented binding is reduced 70%–80% by the
OS inhibitor N-nitro-L-arginine methyl ester (L-NAME)
s well as by the NMDA antagonist MK801.
To ascertain the specific cysteines involved in the
-nitrosylation of NSF, we conducted MALDI-mass
pectrometric analysis of NSF in the presence of GSNO
ollowed by labeling the S-nitrosylated cysteines with
PDP-biotin (Figure 1G). This procedure identifies cys-
eine-91 as the S-nitrosylated residue.
NSF is comprised of three domains: the D1 domain,
hich mediates ATP hydrolysis; the D2 domain, which
articipates in homo-oligomerization; and the N-ter-
inal domain, which mediates binding to other proteins
Whiteheart and Matveeva, 2004). Each of these con-
ains three conserved cysteines. To obtain more defin-
tive evidence that C91 participates in NSF-GluR2 bind-
ng, we mutated it to alanine and compared this mutant
o C11A and C21A, the other cysteine residues con-
ained in the N-terminal domain of NSF. The C91A mu-
ation abolishes stimulation of NSF-GluR2 binding by
NAP, while a 2- to 3-fold augmentation of binding is
bserved in C11A, C21A, and wild-type preparations
Figures 1H and 1I). Interestingly, the C91A mutation
ugments NSF-GluR2 binding in the absence of NO do-
or treatment, suggesting that it leads to a conforma-
ional alteration that facilitates binding of the two pro-
eins.
To determine whether S-nitrosylation influences sur-
ace expression of GluR2, we imaged surface mem-
rane GluR2 with the total internal reflection fluores-
ent microscopy (TIRFM) technique (Axelrod, 2001).
igure 2A shows the typical epifluorescent and TIRFM
mages from HEK293 cells transfected with GFP-
agged GluR2 (GluR2-GFP). TIRFM imaging clearly re-
eals GluR2 clusters at the membrane surface. TIRFM
an monitor the surface insertion of GluR2 in real-time
nd with a greater temporal resolution than surface bio-
inylation and immunostaining. Moreover, combining
IRFM with photobleaching enhances clarity and sensi-
ivity by selectively reducing basal GFP fluorescence at
urface membranes without damaging cells. We there-
ore used it to investigate the effect of NO on GluR2
NSF Nitrosylation and AMPAR Surface Expression
535Figure 2. Real-Time Imaging of AMPAR Surface Expression by Total Internal Reflection Fluorescence Microscope
HEK293 cells were transiently transfected with GluR2-GFP. (A) Representative images of HEK293 cells taken under light, epifluorescent, and
TIRF microscopes. (B and C) Fluorescent signals at the plasma membrane and in vesicles docked to the plasma membrane were bleached
by evanescent wave exposure. The subsequently recovered GFP fluorescence, representing GluR2 newly inserted into plasma membrane,
was monitored by time-lapse recording with an interval of 0.6 s. Equilibrium between fluorescent photobleaching and recovery occurs within
5–10 min with NO donors applied afterward. Selective images (one in every three frames) from a time-lapse recording show the increased
fluorescent signals elicited by 0.5 mM SNP (B) or by 0.5 mM CSNO (C) (also seen in Movie S1). (D) The average intensity of fluorescent signals
is relatively stable throughout the imaging protocol (0.2–0.4 s for exposure, 0.6 s for interval) (control trace). The fluorescent intensity in each
frame was normalized to the fluorescence at the first frame. Fluorescence intensity increases markedly within 5 s after treatment with SNP
(0.5 mM). (E) The effect of SNP on fluorescent intensity is mediated by NO release, as decayed SNP is inactive. (F) GFP-tagged PH domain
derived from Akt was used as a negative control. (G) A physiologically relevant NO donor CSNO (0.5 mM) also stimulates surface expression
of GluR2-GFP. (H) Decayed CSNO fails to stimulate surface expression of GluR2. (I) The stimulatory effect of NO on the surface expression is
attenuated in mutant GluR2 (A849-Q853) with a deletion at its C-tail. (J) Quantification of fluorescent intensities at 20 s after SNP treatment
(69% ± 17%; n = 5) and at 30 s after CSNO treatment (39% ± 13%; n = 7). Data are presented as mean ± SEM (*p < 0.05). (K) Quantification
of fluorescent intensities of wild-type GluR2-GFP and mutant GluR2-GFP (A849-Q853) (58% ± 22% for wild-type GluR2- GFP and 16% ± 5%
for mutant GluR2-GFP; n = 8; p < 0.05) at 40 s after NO treatment.
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536receptors (Dingledine et al., 1999). The NO donors SNP
and S-nitrosocysteine (CSNO) elicit a rapid, time-
dependent surface insertion of GluR2 (Figures 2B, 2C,
2D, 2G, and 2J; Movie S1). The actions of the NO do-
nors depend on physiologically active NO, as no sur-
face insertion of GluR2 is observed with decayed SNP
or CSNO (Figures 2E and 2H). Translocation to the sur-
face is selective for GluR2-GFP, as the PH domain of
Akt, which can be found in both cytosol and plasma
membrane, does not move to the surface in the pres-
ence of SNP (Figure 2F). Translocation of GluR2-GFP
depends on its interaction with NSF, as selective dele-
tion of the portion of GluR2 (A849-Q853) that mediates
binding to NSF but retains the interaction with AP2 (Lee
et al., 2002) markedly reduces NO-mediated surface
expression (Figures 2I and 2K).
Activation of synaptic NMDARs by the coagonist gly-
cine increases AMPA receptor membrane insertion and
induces LTP of synaptic transmission (Lu et al., 2001;
Man et al., 2003; Lin et al., 2004). We used this model
to test whether selectively activating synaptic NMDARs
can elicit S-nitrosylation of NSF that regulates GluR2
surface expression. Treatment of neurons with 200 M
glycine induces NO production (Figure 3A). This induc-
tion is completely blocked both by the NMDAR antago-
nist MK801 and the NOS inhibitor L-NAME, indicating
that activation of synaptic NMDAR is sufficient to stim-
ulate NOS activity. Glycine treatment leads to NSF
S-nitrosylation, which is abolished by MK801 or L-NAME
(Figures 3B and 3C). To investigate whether S-nitrosyla-
tion of NSF promotes surface expression of GluR2 in
neurons, we initially employed TIRFM in neurons as we
did in HEK 293 cells. Glycine treatment induces a rapid F
lsurface insertion of GluR2-GFP (Figure S1C). The effect
(elicited by glycine is markedly attenuated by the NOS
minhibitor L-NAME or the NMDAR antagonist MK 801
1(Figures S1D–S1F). One limitation of TIRFM in neurons
Lis the fast decay of fluorescent signal by photobleach
b
during image recording as is evident in Figure S1A. The S
photobleaching process appears to be responsible for t
othe brief (about 40 s) glycine-elicited response (Figure
pS1C). We therefore used an alternative immunostaining
nassay to measure the GluR2-GFP plasma membrane
insertion. Briefly, the pre-existing membrane GluR2-
GFP was blocked with an anti-GFP antibody bound N
with an unconjugated secondary antibody (Figure 4). i
The newly inserted GluR2-GFP was visualized with an
anti-GFP antibody prebound with Cy3-conjugated sec- S
ondary antibody. Within 5 min, glycine treatment mark- r
edly augments the surface insertion of GluR2-GFP (Fig- f
ures 4A and 4E), predominantly in processes whose s
synaptic terminals are imaged by bassoon (Wilson, v
2003) (Figure S4). The glycine-induced GluR2-GFP in- H
sertion is blocked by L-NAME (Figures 4A and 4E), indi- a
cating that surface insertion of GluR2 is mediated by N
NO. Levels of membrane-inserted GluR2 remain higher t
than control at 15 min (Figures 4B and 4E), consistent s
with the long-lasting effect of glycine on synaptic trans- l
mission (Lu et al., 2001; Man et al., 2003). In contrast, f
glycine treatment has little effect on the surface inser- N
tion of GluR2 mutant with a small C-tail deletion (A849-
Q853) (Lee et al., 2002) that selectively disrupts its in- c
iteraction with NSF (Figures 4C and 4E), confirming thatigure 3. Activation of Synaptic NMDARs Leads to NSF S-Nitrosy-
ation
A) Activation of NOS in primary cortical neurons by glycine treat-
ent (200 M) (1113 ± 296 for control; 2233 ± 391 for glycine; 600 ±
76 for glycine plus MK801 [10 M]; 1300 ± 117 for glycine plus
-NAME [300 M]; n = 3; *p < 0.05). NOS activity was determined
y measuring the formation of [3H]citrulline from [3H]arginine. (B)
-nitrosylation of NSF induced by glycine treatment. NSF nitrosyla-
ion was determined by a biotin-switch method. (C) Quantification
f S-nitrosylated NSF (2.13 ± 0.35 for glycine; 0.95 ± 0.13 for glycine
lus MK801 [10 M]; 1.08 ± 0.07 for glycine plus L-NAME [300 M];
= 3; *p < 0.05).O-induced surface insertion of GluR2 is mediated by
ts interaction with NSF.
The main findings of this study are that physiologic
-nitrosylation of NSF enhances its binding to GluR2,
egulating the receptor’s surface expression. These
indings clarify the role of NO in synaptic plasticity. NSF
tabilizes AMPARs at synapses, presumably by pre-
enting PICK1-mediated endocytosis (Lee et al., 2002;
anley et al., 2002). Thus, activation of synaptic NMDARs
ugments NO formation, which elicits S-nitrosylation of
SF whose binding to GluR2 is thereby augmented,
herefore facilitating insertion or stabilizing AMPAR at
ynapses by disrupting GluR2-PICK1 interactions (Han-
ey et al., 2002). This cellular mechanism might account
or the induction of LTP following activation of synaptic
MDARs (Lu et al., 2001).
We found that activation of synaptic NMDAR by gly-
ine treatment, a protocol used for the induction of LTP
n cultured neurons (Lu et al., 2001), facilitates the
NSF Nitrosylation and AMPAR Surface Expression
537Figure 4. NO Facilitates Surface Insertion of GluR2 in Cultured Cortical Neurons
(A) Representative double-labeled images of neurons expressing GluR2-GFP (green) with surface staining of newly inserted GluR2 (red) after
5 min treatment with glycine or glycine plus L-NAME. (B) Surface staining of newly inserted GluR2 (red) at 15 min after glycine treatment. (C)
Surface staining of newly inserted mutant GluR2 (A849-Q853) after 5 min glycine treatment. (D) Immunostaining of surface GluR2 before (top)
and after the blockage of pre-existing surface GluR2-GFP (bottom). The boxed inset in each image is the higher magnification of the region
marked with *. (E) Quantification of immunostaining intensity of newly inserted GluR2 in neurons (wild-type GluR2-GFP at 5 min: 1.04 ± 0.15
for control; 1.97 ± 0.20 for glycine [200 M]; 0.87 ± 0.08 for glycine plus L-NAME [300 M]; wild-type GluR2-GFP at 15 min: 1.11 ± 0.03 for
control and 1.39 ± 0.10 for glycine; mutant GluR2-GFP at 5 min; 0.83 ± 0.05 for control and 0.93 ± 0.13 for glycine; n = 6; *p < 0.05).GluR2 surface expression. The findings appear incon-
sistent with a previous report in which glycine stim-
ulated surface insertion of GluR1, but not GluR2 (Pas-
safaro et al., 2001). This discrepancy may reflect
experimental differences. Passafaro et al. (2001) used
substantially lower concentrations of glycine, which
may not suffice to induce GluR2 surface insertion. Also,thrombin pretreatment used in their experiments may
cause undesired cellular responses, e.g., thrombin
stimulates exocytosis in human aortic endothelial cells
(Matsushita et al., 2003), activates PAR1 signaling in
neurons (Junge et al., 2003), and potentiates hippo-
campal NMDAR responses in CA1 pyramidal cells (Gin-
grich et al., 2000).
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538mThe NO-elicited coimmunoprecipitation of NSF and
gGluR2 requires nonhydrolyzable ATP analogs to inhibit
bNSF’s ATPase activity, resembling conditions required
b
to detect NSF-SNARE complexes (Sollner et al., 1993a). d
Thus, S-nitrosylation of the N-terminal domain of NSF w
rdoes not compromise its ATPase activity, consistent
pwith a previous report (Matsushita et al., 2003) and our
lobservations (Figure S2). It appears that S-nitrosylation
bof NSF facilitates its binding to the GluR2-PICK1 com-
t
plex via interacting with GluR2, while the intact ATPase 2
activity may be required for disrupting GluR2-PICK1 w
rcomplex, thereby enhancing GluR2 surface expression.
eProtein S-nitrosylation, a reversible posttranslational
Imodification, has recently emerged as a pervasive cell
0signaling mechanism with neurally derived NO nitrosy-
o
lating multiple brain proteins (Jaffrey et al., 2001). d
S-nitrosylation may account for cerebellar LTP that is i
independent of cyclic nucleotides (Lev-Ram et al.,
D2002, Lev-Ram et al., 2003), as well as cerebellar LTP
Rthat requires NSF (Steinberg et al., 2004).
1
wExperimental Procedures
s
NDetection of In Vivo S-Nitrosylated Proteins
wCerebellar tissues dissected from wild-type and nNOS knockout
pmice were homogenized in HEN buffer (250 mM HEPES, pH 7.7, 1
5mM EDTA, 0.1 mM neocuproine) and further solublized in 0.5%
0CHAPS on ice for 10 min. The cell lysates were centrifuged at 2000 ×
Sg for 10 min at 4°C to remove nuclei and other insoluble materials.
wS-nitrosylated proteins were biotinylated and isolated from the cell
lysates using the biotin-switch method as described previously I(Jaffrey et al., 2001) and were detected by immunoblotting using
Tantibodies against NSF (Song et al., 1998), synaptophysin (Chemi-
scon), and Na/K ATPase α1 (Upstate Biotechnology Inc.). Signals on
OWestern blots were quantified with NIH Image software. S-nitrosy-
tlation of NSF in cultured cortical neurons was assayed as de-
cscribed above, except that neurons were treated with 200 M of
Cglycine in Mg2+-free ACSF (with 0.5 M TTX, 1 M strychnine, and
q20 M bicuculline methiodide) in the presence or absence of 10
c
M MK801 or 300 M L-NAME for 30 min before lysing cells.
T
(
Preparation of Recombinant Proteins s
A full-length cDNA of NSF was isolated from a rat cDNA library (a p
gift from Dr. Anthony Lanahan) by PCR with a pair of oligos (up- s
stream, 5#-GGGTCGACTATGGCGGGCCGGAC; downstream, 5#- g
GCGGCCGCTCAGTCAAAGTCCA) using high-fidelity polymerase c
(Roche Molecular Biochemicals), subcloned into TA cloning vector e
PCR 2.1 vector or pcDNA3 vector (Invitrogen), and confirmed by v
DNA sequencing. NSF cysteine mutants were generated by Quick v
Exchange kit (Stratagene). The His-tagged NSF proteins were puri- f
fied from Top-10 strain bacteria (Invitrogen) using Ni-NTA agarose a
affinity chromatography (Qiagen). Recombinant protein of GST- R
GluR2 C terminus (Song et al., 1998) was purified using Glutathi- q
one-Sepharose affinity chromatography (Amersham Pharmacia w
Biotech). d
w
GST Pull-Down Assays and Coimmunoprecipitation N
For in vitro binding assays, recombinant NSF (2 g) and its mutants m
in 60 l aliquots were pretreated with NO donors for 4 hr at 4°C in
the dark. NO donors (100 M GSNO, 200 M SNAP, 50 M SIN1) N
were removed by micro Bio-Spin P6 columns (Bio-Rad). NO- P
treated recombinant NSF proteins were then incubated with GST- 1
R2 (2 g) prebound to 15 l of Glutathione-Sepharose beads in 500 B
l binding buffer (25 mM HEPES, pH 7.4; 150 mM NaCl; 3 mM t
MgCl2; 0.5 mM AMP/PNP; 1% Triton X-100; 5% glycerol) for 1 hr. 2
Beads were washed with binding buffer four times. Bound proteins f
were eluted in 2× sample buffer and detected by immunoblotting
using antibodies against His (Santa Cruz Biotechnology Inc.) or S
GST (Invitrogen) tags. Hippocampal tissues from rats or mice were S
ahomogenized in ice-cold lysis buffer (as mentioned above) with 0.5M ATP or AMP/PNP). The lysates were then centrifuged at 16,000 ×
at 4°C for 15 min. Supernatants were preabsorbed with protein A
eads (Amersham Pharmacia Biotech) for 1 hr. After removal of
eads by centrifugation, the supernatants were treated with NO
onors for 4 hr at 4°C in the dark and were subsequently incubated
ith 1 g of monoclonal anti-GluR2 antibody (against N-terminal
egion of GluR2) (Zymed) for 1 hr at 4°C. The GluR2 protein com-
lexes were precipitated with protein A beads and washed with
ysis buffer four times. Bound proteins were eluted with 2× sample
uffer, resolved in SDS-PAGE gels, and detected by immunoblot-
ing using rabbit anti-NSF and mouse anti-GluR2 antibodies. About
%–3% of the amount of lysate used for coimmunoprecipitation
as loaded into gel as input. Wild-type and nNOS knockout mice
eceived a single episode of electroconvulsive seizure via earclip
lectrodes using constant current generator (Ugo Basile, Comerio,
taly) with the following stimulus parameters: 14 mA; pulse width,
.4 ms; 85 pulses/s for 1 s. Hippocampal tissues were dissected
ut from mice within 30 min after shock. Lysates were prepared as
escribed above. Coimmunoprecipitation assays were performed
mmediately without adding NO donors.
etection of S-Nitrosylated Cysteines by Mass Spectrometry
ecombinant NSF protein (50 g) in HENS buffer was treated with
00 M GSNO at room temperature for 30 min and then labeled
ith HPDP-biotin as described (Jaffrey et al., 2001). The protein
amples were subsequently dialyzed against 4 L of 100 mM
H4CO3 buffer at room temperature for 4 hr. The recovered proteins
ere digested with trypsin (Promega) at 37°C overnight to generate
eptides that were cleaned with C18 Ziptip (Millipore) and eluted in
0% acetonitrile, 10 mg/ml α-cyano-4-hydroxycinnamic acid, and
.1% TFA for MALDI-TOF. Mass spectra were obtained on a Per-
eptive Voyager MALDI-TOF (Applied Biosystems) and analyzed
ith Data Explorer software (Applied Biosystems).
mage Acquisition and Processing
IRFM was performed using the Olympus total internal reflection
ystem including an inverted epifluorescence microscope (IX-70,
lympus, Melville, NY) and a high-numerical-aperture (NA) objec-
ive (Apo X 60 NA 1.45, Olympus). GFP-tagged proteins were ex-
ited by light from an argon laser (488 nm, Melles Griot, Carlsbad,
A). Time-lapse sequences of images (1 to 2 frames s−1) were ac-
uired by CCD camera (Hmamatsu Photonics, Bridgewater, NJ)
ontrolled by METAMORPH (Universal Imaging, Downingtown, PA).
he depth of the evanescent field is typically about 70–100 nm
Schmoranzer et al., 2000). To facilitate the detection of the new
urface-expressed GFP-tagged proteins, GFP fluorophores at the
lasma membrane as well as in docking and fusing vesicles were
electively photobleached by evanescent wave exposure at the be-
inning of each experiment until equilibrium between the GFP exo-
ytosis and photobleaching during image recording (0.2–0.4 ms for
xposure, 0.6 s for interval). Analysis of video sequences and indi-
idual frames was done with METAMORPH and Excel. To clearly
isualize the alteration in the intensity of GFP signals, the average
luorescent intensity of all the frames in a time-lapse sequence was
utomatically calculated by METAMORPH and Excel (Microsoft,
edmond, WA) and subtracted from individual frames in the se-
uence. HEK293 cells and primary cultured hippocampal neurons
ere plated on 35 mm dishes with a glass coverslip (refractive in-
ex n = 1.8 at 488 nm, Olympus). Prior to imaging, culture medium
as replaced with ACSF (124 mM NaCl, 3 mM KCl, 1.25 mM
a2HPO4, 1.6 mM CaCl2, 1.8 mM MgSO4, 10 mM D-glucose, 10
M HEPES, pH 7.4) for HEK293 cells.
euronal Culture and Transfection
rimary hippocampal neurons were prepared from embryonic day
8–19 rat brains in neurobasal media with B27 supplement (Gibco
RL, Rockville, MD). Low-density neurons at 15 days in vitro were
ransfected with N-terminal GFP-tagged GluR2 using lipofectamine
000. Neurons were used for experiments 36–48 hr after trans-
ection.
urface Insertion Assay
imilar procedures were followed as previously described (Lu et
l., 2001; Man et al., 2003). Briefly, surface GluR2-GFP was blocked
NSF Nitrosylation and AMPAR Surface Expression
539by incubating neurons with a polyclonal anti-GFP antibody for 40
min and an unconjugated secondary anti-rabbit antibody for 30 min
at 10°C. After three times of washing with ACSF, neurons were re-
turned to 37°C for 5 min, with glycine alone (200 M) or together
with L-NAME (300 M), to allow for receptor surface insertion. For
some experiments, glycine was removed after 5 min treatment, and
the cells were then maintained for another 10 min at 37°C. After 10
min of fixation in 4% paraformaldehyde/4% sucrose at 4°C, the
newly inserted GluR2-GFP was labeled with a polyclonal anti-GFP
antibody prebound with Cy3-conjugated secondary antibody (Jack-
son ImmunoResearch, West Grove, PA) at room temperature for 1
hr. Neurons were then washed extensively with ice-cold ACSF for
three times. Images were acquired with a fluorescent microscope.
NOS Activity Assay
NOS activity was assessed by measuring the conversion of L-argi-
nine to citrulline as described previously (Bredt and Snyder, 1989).
Briefly, cells were washed twice with ACSF and incubated with 10
l of L-[2, 3 3H] arginine (1 mCi/ml, NEN) at 37°C for 10 min. Cells
were then treated with 200 M of glycine for 30 min in the presence
or absence of 10 M of MK801 or 300 M L-NAME. The conversion
of arginine to citrulline was terminated by adding ice-cold methanol
and incubated on ice for 20 min. The supernatant was evaporated
to dryness and resuspend in 20 mM Tris buffer (pH 7.4). An aliquot
of supernatant was applied to a Bio-Rad Econo Column with
Dowex AG50WX8 resin. The [3H] citrulline fraction that passed
through the resin was collected. The radioactivity of each sample
was determined by liquid scintillation counting.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/46/4/533/DC1/.
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